SHARE THIS VIDEO —
Cheaper alternative to arthritis drug Humira nears FDA approval
A Food and Drug Administration panel approved Agmen’s version of the drug Humira. If approved, it will offer patients a less expensive alternative for rheumatoid arthritis medication. (Run time: 0:27)